Montreal, September 20, 2018 – IRICoR is proud to launch, today with the Oncopole, this new LeadAction-Onco Competition. This joint call for projects, in partnership with the FRQS, is an opportunity for researchers from Quebec and the rest of Canada to accelerate the transformation of their projects in oncology and immuno-oncology into novel therapies for the benefit of patients.
“As the Centre of Excellence for Commercialization and Research at the heart of Canada’s drug discovery ecosystem, IRICoR supports the best projects in cancer and related fields from cutting-edge research in Quebec and across Canada. Working with a key player like the Oncopole to make this LeadAction-Onco Competition a reality was a step for us. Through this call, selected projects will be added to IRICoR’s project portfolio and will benefit from IRICoR’s expertise in drug discovery, project management, intellectual property and business development and its national and international networks. “Nadine Beauger, Chief Executive Officer of IRICoR.
For more information, please visit the LeadAction-Onco contest page here
